Innate Pharma Balance Sheet (2017-2026)

Reported Financials

Innate Pharma Quarterly Balance Sheet

Periods 17 quarters

Latest Jun 2026

Innate Pharma reported total assets of $40.36M and total liabilities of $87.45M for the quarter ended Jun 2026, down 72.5% year over year. This balance sheet covers 17 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Dec2017	Dec2018	Jun2019	Dec2019	Jun2020	Dec2020	Jun2021	Dec2021	Jun2022	Dec2022	Jun2023	Dec2023	Jun2024	Dec2024	Jun2025	Dec2025	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	117.00M	173.85M	171.15M	224.57M	131.54M	163.10M	125.22M	118.69M	109.85M	85.93M	91.71M	75.97M	76.03M	70.95M	75.16M	32.70M	7.51M
Receivables - NetNet Receivables	25.21M	173.62M		31.79M	15.95M	61.56M	54.34M	55.19M	65.66M	53.51M	61.47M	71.13M	36.91M	15.28M	19.23M	14.73M	10.26M
Receivables	25.21M	173.62M		31.79M	15.95M	61.56M	54.34M	55.19M	65.66M	53.51M	61.47M	71.13M	36.91M	15.28M	19.23M	14.73M	10.26M
Current Assets	161.92M	364.84M		263.00M	163.69M	206.80M	156.18M	158.16M	183.32M	142.66M	157.30M	159.25M	120.17M	91.62M	73.55M	54.37M	22.78M
Non-Current Assets
Buildings								0.02M
Property, Plant & Equipment (Net)	12.63M	11.66M		12.92M	12.43M	13.94M	13.12M	11.64M	10.20M	8.71M	7.91M	6.80M	6.20M	5.49M	5.61M	5.07M	4.23M
Intangibles	54.39M	96.48M		107.33M	95.22M	55.19M	54.42M	50.55M	46.16M	1.59M	0.98M	0.45M	0.13M
Goodwill & Intangibles	54.39M	96.48M		107.33M	95.22M	55.19M	54.42M	50.55M	46.16M	1.59M	0.98M	0.45M	0.13M
Long-Term Deferred Tax		1.78M		1.42M	1.27M	8.45M	6.50M	5.75M	8.30M	8.74M	10.53M	9.69M	9.82M
Other Non-Current Assets	0.13M	0.10M		0.10M	0.14M	0.18M	0.25M	0.17M	0.16M	0.15M	0.09M	0.09M	0.09M	0.61M	0.65M	1.10M	1.02M
Non-Current Assets	138.35M	150.18M		181.26M	169.38M	159.73M	164.42M	147.85M	115.92M	60.67M	59.45M	29.24M	42.97M	27.05M	31.65M	18.64M	17.58M
Assets	300.27M	515.02M		444.26M	333.07M	366.54M	320.60M	306.01M	234.42M	203.33M	216.75M	188.49M	146.91M	118.68M	105.20M	73.01M	40.36M
Liabilities
Current Liabilities
Accounts Payables	29.03M	104.61M		54.80M	26.54M	35.22M	20.50M	32.69M	19.92M	21.33M	20.68M	18.31M	17.09M	17.11M	13.63M	17.51M	13.10M
Payables	29.03M	104.61M		54.80M	26.54M	35.22M	20.50M	32.69M	19.92M	21.33M	20.68M	18.31M	17.09M	17.11M	13.63M	17.51M	13.10M
Short term Debt	1.58M	1.54M		2.36M	2.04M	2.55M	2.43M	35.17M	32.92M	2.14M	5.81M	9.61M	9.62M	9.31M	10.11M	10.25M	12.54M
Current Taxes		23.95M		23.58M	12.01M	53.48M	46.30M	37.75M	62.91M	54.06M	53.92M	48.45M	45.12M	43.95M	39.07M	36.96M	35.59M
Current Deferred Revenue	158.85M	171.43M		98.64M	68.37M	-53.82M	45.84M	-6.93M	-21.86M	-23.91M	-3.76M	-4.30M	-3.84M
Total Current Liabilities	87.02M	224.55M		134.84M	82.34M	54.23M	51.32M	91.39M	78.49M	42.17M	41.02M	42.65M	41.16M	35.24M	33.31M	42.66M	38.19M
Non-Current Liabilities
Non-Current Debt	5.32M	3.62M		18.37M	16.78M	20.20M	17.44M	15.45M	13.36M	40.96M	38.46M	33.31M	28.62M	23.81M	20.48M	16.03M	10.94M
Convertible Debt				75.52M	49.96M	57.97M		83.31M	66.20M	64.44M		61.23M	55.33M
Non-Current Deffered Revenue	56.41M	93.70M		53.98M	41.58M	13.47M	-45.84M	14.30M	-18.60M	6.69M	-12.00M	6.31M	3.01M	0.66M	0.64M	3.29M	0.15M
Pension	3.09M	4.22M		4.16M	4.16M	4.98M	4.67M	3.40M	2.88M	2.60M	2.76M	2.63M	2.66M	2.92M	3.02M	2.24M	2.27M
Operating Leases	1.19M	0.04M		0.16M	0.17M	0.81M	6.77M	0.74M	0.83M	1.57M	1.91M	0.65M	0.40M	0.29M	1.25M	4.05M	1.95M
Non-Current Deferred Tax Liability		1.78M		1.42M	1.27M	8.45M	6.50M	5.75M	8.30M	8.74M	10.53M	9.69M	9.82M
Total Non-Current Liabilities	112.04M	99.57M		68.76M	42.96M	126.33M	108.43M	91.71M	96.61M	105.91M	112.72M	90.00M	90.97M	73.99M	66.07M	55.61M	49.26M
Total Liabilities	199.06M	324.13M		203.61M	125.30M	180.57M	159.75M	183.10M	110.28M	148.08M	153.74M	132.65M	115.90M	109.24M	99.38M	98.27M	87.45M
Shareholder's Equity
Total Debt	6.90M	5.16M		20.72M	18.82M	22.76M	19.87M	50.62M	46.28M	43.11M	44.27M	42.92M	38.23M	33.12M	30.60M	26.28M	23.49M
Common Equity	101.21M	190.89M		240.66M	207.76M	185.97M	160.84M	122.91M	124.13M	55.25M	63.01M	55.84M	31.01M	9.44M	5.82M	-25.26M	-47.08M
Liabilities and Shareholders Equity	300.27M	515.02M		444.26M	333.07M	366.54M	320.60M	306.01M	234.42M	203.33M	216.75M	188.49M	146.91M	118.68M	105.20M	73.01M	40.36M
Retained Earnings	-121.98M	-157.33M		-149.33M	-155.72M	-186.56M	-265.46M	-250.99M	-290.50M	-277.72M	-359.69M	-354.33M	-362.80M	-360.00M	-437.35M	-449.75M	-506.26M

Innate Pharma Balance Sheet API

Pull Innate Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IPHA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "IPHA", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=IPHA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Innate Pharma IPHA Balance Sheet (2017-2026)

Innate Pharma Quarterly Balance Sheet

Innate Pharma Balance Sheet API

Create an account

Sign In

Reset Password